Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Netflix, Q4 2024 and Earnings Call
Halliburton (HAL) Q4 2024 Earnings Call Transcript
Halliburton (NYSE: HAL) Q4 2024 Earnings Call Jan 22, 2025, 9:00 a.m. ET Good day, and thank you for standing by. Welcome to the Q4 2024 Halliburton Company earnings conference call. At this time, all participants are in a listen-only mode. Please be advised that today's conference is being recorded.
Netflix (NFLX) Q4 2024 Earnings Call Transcript
Good afternoon, and welcome to the Netflix Q4 2024 earnings interview. I'm Spencer Wang, vice president of finance, IR, and corporate development. Joining me today are co-CEOs, Ted Sarandos and Greg Peters; and CFO, Spence Neumann. As a reminder, we will be making forward-looking statements, and actual results may vary.
Netflix Inc. Q4 Profit Climbs, Beats Estimates
Netflix Inc. (NFLX) released earnings for its fourth quarter that increased from the same period last year and beat the Street
Ally Financial (ALLY) Q4 2024 Earnings Call Transcript
Thank you, Daniel. Good morning, and welcome to Ally Financial's fourth quarter and full year 2024 earnings call. This morning, our CEO, Michael Rhodes; and our CFO, Russ Hutchinson, will review Ally's results before taking questions. The presentation we'll reference can be found on the investor relations section of our website, ally.com.
Netflix: Q4 Earnings Snapshot
The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $4.20 per share. The internet video service posted revenue of $10.25 billion in the period, also exceeding Street forecasts.
Netflix Q4 Earnings Beat, Revenues Rise Y/Y on Subscriber Gain
Netflix NFLX shares jumped more than 14% in pre-market trading after the company reported fourth-quarter 2024 earnings of $4.27 per share, which beat the Zacks Consensus Estimate by 1.67%. The figure jumped 102.
Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings
Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the look-back and look-ahead on an earnings call,
Netflix Q4 results top estimates after blowout subscriber numbers
Netflix surged in afterhours trading Tuesday after reporting better-than-expected Q4 results as subscriber adds soared.
Live Earnings Blog: Will Netflix (NFLX) Soar After Announcing Q4 Earnings Tonight?
Netflix (Nasdaq: NFLX) highlights tonight’s earnings schedule. The company had a scorching-hot 2024, shares are up 79% in the past 12 months. Can the company continue building on this momentum in 2025?
3h
on MSN
GE Aerospace Q4 2024 earnings preview: All eyes on annual margin, delivery projections
GE Aerospace (NYSE:GE) is scheduled to announce Q4 earnings results on Thursday, January 23rd, before market opens. Citi ...
JD Supra
2h
State and Federal PFAS Litigation – 2019 to Q4 2024
PFAS-related litigation continues to climb and to diversify as to claims and parties. See the attached graphics, updated ...
GM Authority
16h
U.S. Chevrolet Sales Grew Impressive 17 Percent During Q4 2024
Chevrolet sales grew 17 percent to 481,064 deliveries during Q4 2024 in the U.S. See Chevrolet USA sales figures, numbers, ...
10h
The Optimist Fund Q4 2024 Quarterly Letter
Since inception, we have achieved approximately 15% annualized returns, net of fees, and are now approaching our 3- year ...
9h
Riverwater Partners Micro Opportunities Strategy’s Q4 2024 Investor Letter
Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q4 2024 investor letter.
JD Supra
3h
Life Sciences Law Update - Key developments for pharma and medical device companies in EU and Germany, France, UK, Italy and Spain in Q4/ 2024
Pharma: Launch of Shortages Monitoring Platform, several Changes re Clinical Trial Management in EU Countries; Devices: Resolution on the need ...
8h
Kingdom Capital Advisors Q4 2024 Investor Letter
Kingdom Capital Advisors (KCA Value Composite) returned 2.07% (net of fees) in 4Q, vs. 0.33% for Russell 2000 TR, 2.41% for S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Netflix
United States
Earnings Call Transcript
Regions Financial Corporation
Citigroup
Feedback